|
Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. J Clin Oncol. 2008 Apr 10;26(11):1843-9. doi: 10.1200/JCO.2007.13.7265. PubMed PMID: 18398150.
AÑO: 2008; IF: 17.157
|
18398150
|
Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. J Clin Oncol. 2007 Jan 1;25(1):16-24. PubMed PMID: 17194902.
AÑO: 2007; IF: 15.484
|
|
Hernández-Espinosa D, Miñano A, Martínez C, Pérez-Ceballos E, Heras I, Fuster JL, Vicente V, Corral J. L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases. Am J Pathol. 2006 Jul;169(1):142-53. PubMed PMID: 16816368; PubMed Central PMCID: PMC1698772.
AÑO: 2006; IF: 5.917
|
|
de Arriba F, Corral J, Ayala F, Heras I, Moraleda JM, Osma MM, González-Conejero R, Ortuño F, Vicente V. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer. Bone Marrow Transplant. 1999 Mar;23(6):621-4. PubMed PMID: 10217194.
AÑO: 1999; IF: 2.378
|
|
Osma MM, Ortuño F, de Arriba F, Heras I, Moraleda JM, Garcia VV. Preleukapheresis peripheral blood CD34+ cells predict progenitor cell collection yield and the necessary number of procedures to undergo. Haematologica. 1999 Mar;84(3):280-1. PubMed PMID: 10189398.
AÑO: 1999; IF: 3.226
|